Oracle Investment Management Inc Immunity Bio, Inc. Transaction History

Oracle Investment Management Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$3.65 - $6.43 $1.15 Million - $2.03 Million	315,322 New	315,322 $1.57 Million
Q2 2022 Aug 15, 2022	SELL	$2.68 - $6.14 $1.07 Million - $2.46 Million	-400,013 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$5.05 - $7.53 $2.02 Million - $3.01 Million	400,013 New	400,013 $2.24 Million

202

70M

1.68M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.8B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Oracle Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Oracle Investment Management Inc with notifications on news.